4.7 Article

Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease

Journal

CLINICAL INFECTIOUS DISEASES
Volume 61, Issue 6, Pages 969-973

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/civ395

Keywords

Ebola; investigational therapies; trials

Ask authors/readers for more resources

From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa. We present a patient with EVD who received brincidofovir and convalescent plasma. The relative contributions of supportive care, investigational therapies, and patient's immune-response on survival could not be determined. Randomized trials are needed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available